Stock Updates

How has Edwards Lifesciences Corp.:(NYSE:EW) performed recently?

Edwards Lifesciences Corp. (NYSE: EW) is a large market cap stock with a market cap of 24431.66. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of 47.69, a forward P/E of 33.9 and EPS of 2.42. At a stock price of 115.26 (0.43%) it has a dividend yield of *TBA.

EPS growth for the last five years have been 19.70%, more recently this last year it has grown by -39.80%. The next year growth is going to be about 18.10% and more long-term 17.68% after five years. EPS growth quarter over quarter is 13.70%. Sales growth for the past five years have been 11.50% and sales growth quarter over quarter is 23.10%.

For performance, Edwards Lifesciences Corp. the past week has seen a gain of -2.38%. For the last month performance for Edwards Lifesciences Corp. is 2.01%. While the last quarter is 15.21% and half year, 32.48%. Finally for the year, performance is 58.34%.

The 52-week high for Edwards Lifesciences Corp., is at -3.08%, and for the 52-week low it comes to a value of 73.14%. The 20-day simple moving average is 7.26% and 22.71% for the 200-day simple moving average.

Volatility for the week is at 1.87%, and for the month it is 1.61%. Edwards Lifesciences Corp., has a target price of 123.95.

In terms of debt, long term debt/equity is 0.24, and for total debt/equity Edwards Lifesciences Corp. has 0.24. The gross margin is 74.30%, while operating margin is 24.40%, the profit margin is 19.30%. The current ratio is 4.2 and the quick ratio is 3.4.

Insider ownership is at 0.30%, with instituitional ownership at 87.10%. Edwards Lifesciences Corp. has a payout ratio of 0.00%. With the total shares outstanding coming to 211.97. The shares float is 211.29, with the float short at 1.77%, with short ratio coming to 2.51.

In terms of returns, the return on assets see Edwards Lifesciences Corp., get 13.30%, with its returns on investment at 15.90%. Return on equity is 21.80%. So will the investors see the target price of 123.95, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment